-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca Executive Sees Path for Bone-Disease Drug Approval Despite Trial Miss -- Interview

Dow Jones·10/11/2026 21:00:00

请登录查看新闻详情